Long-Term Opioid Efficacy Act of 2018
Latest action · Jun 20, 2018 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 15, 2018
- Passed HouseJun 19, 2018
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Long-Term Opioid Efficacy Act of 2018
This bill expands the authority of the Food and Drug Administration (FDA) to require post-approval studies or clinical trials with respect to controlled substances (e.g., opioids).
Cosponsors 3
Members who signed on, in the order they did. Signatures ran from May 15, 2018 to Jun 7, 2018; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-VA | H. Morgan Griffith | Original | May 15, 2018 |
| R-OR | Greg Walden | Jun 7, 2018 | |
| R-TN | Marsha Blackburn | Jun 7, 2018 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 15, 2018Markup May 17, 2018 |
| Senate | Health, Education, Labor, and Pensions Committee | Referred Jun 20, 2018 |
Actions 10
Everything that happened, newest first.
- Jun 20, 2018Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Jun 19, 2018Mr. Walden moved to suspend the rules and pass the bill, as amended.
- Jun 19, 2018Considered under suspension of the rules. (consideration: CR H5243-5244)
- Jun 19, 2018DEBATE - The House proceeded with forty minutes of debate on H.R. 5811.
- Jun 19, 2018Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5243)
- Jun 19, 2018Motion to reconsider laid on the table Agreed to without objection.
- May 17, 2018Committee Consideration and Mark-up Session Held.
- May 17, 2018Ordered to be Reported (Amended) by Voice Vote.
- May 15, 2018Introduced in House
- May 15, 2018Referred to the House Committee on Energy and Commerce.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H5243, H5244Text printed H5243 | Greg Walden R-OR, Joseph P. Kennedy III D-MA, Sheila Jackson Lee D-TX | Jun 19, 2018 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Congressional Budget Office cost estimate
- Jun 11, 2018H.R. 5811, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to postapproval study requirements for certain controlled substances, and for other purposesAs ordered reported by the House Committee on Energy and Commerce on May 17, 2018
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 164, no. 79, May 15, 2018, page H3978.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 6 | SUPPORT for Patients and Communities Act | Related bill | Oct 24, 2018 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act with respect to postapproval study requirements for certain controlled substances, and for other purposes.
- Short Titles as Introduced
- Long-Term Opioid Efficacy Act of 2018
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 3
Each version as it was printed, newest first.
- Jun 20, 2018Referred in Senate
- Jun 19, 2018Engrossed in House
- May 15, 2018Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
